Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amoretti

Showing results (251-260 of 346) with videos related to

Pageof 35
Sort By:
Scientific Data|March 3, 2021
Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patientsChen Liao, Bradford P Taylor, Camilla Ceccarani, et al.
Schizophrenia Research|May 20, 2022
The network structure of cognitive deficits in first episode psychosis patientsAna M Sánchez-Torres, Victor Peralta, Gustavo J Gil-Berrozpe, et al.
Revista De Psiquiatria Y Salud Mental|July 15, 2022
Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val<sub>158</sub>Met polymorphism in first episode psychosisElisa Rodríguez-Toscano, Kenia Martínez, David Fraguas, et al.
Schizophrenia Research|March 21, 2024
Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophreniaVicent Llorca-Bofí, Santiago Madero, Silvia Amoretti, et al.
Schizophrenia Bulletin|July 25, 2022
Neutrophil to Lymphocyte Ratio in Patients With a First Episode of Psychosis: A Two-Year Longitudinal Follow-up StudyMiquel Bioque, Ana Catarina Matias-Martins, Vicent Llorca-Bofí, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 1, 2022
Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosisCristina Saiz-Masvidal, Fernando Contreras, Carles Soriano-Mas, et al.
Psychiatry Research|May 13, 2023
Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohortAlex G Segura, Anna Mané, Llucia Prohens, et al.
Psychopharmacology|November 24, 2020
The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosisJ A Arnaiz, C Rodrigues-Silva, G Mezquida, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 17, 2026
The genetic architecture of autistic traits and negative symptoms in non-affective first-episode psychosis: an exploratory longitudinal studyG Mezquida, A Perez-Ramos, N Guasch-Capella, et al.
Schizophrenia Bulletin|February 22, 2020
Examining Gene-Environment Interactions Using Aggregate Scores in a First-Episode Psychosis CohortSergi Mas, Daniel Boloc, Natalia Rodríguez, et al.
Pageof 35

Showing results (251-260 of 346) with videos related to

Sort By:
Pageof 35
Scientific Data|March 3, 2021
Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patientsChen Liao, Bradford P Taylor, Camilla Ceccarani, et al.
Schizophrenia Research|May 20, 2022
The network structure of cognitive deficits in first episode psychosis patientsAna M Sánchez-Torres, Victor Peralta, Gustavo J Gil-Berrozpe, et al.
Revista De Psiquiatria Y Salud Mental|July 15, 2022
Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val<sub>158</sub>Met polymorphism in first episode psychosisElisa Rodríguez-Toscano, Kenia Martínez, David Fraguas, et al.
Schizophrenia Research|March 21, 2024
Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophreniaVicent Llorca-Bofí, Santiago Madero, Silvia Amoretti, et al.
Schizophrenia Bulletin|July 25, 2022
Neutrophil to Lymphocyte Ratio in Patients With a First Episode of Psychosis: A Two-Year Longitudinal Follow-up StudyMiquel Bioque, Ana Catarina Matias-Martins, Vicent Llorca-Bofí, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 1, 2022
Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosisCristina Saiz-Masvidal, Fernando Contreras, Carles Soriano-Mas, et al.
Psychiatry Research|May 13, 2023
Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohortAlex G Segura, Anna Mané, Llucia Prohens, et al.
Psychopharmacology|November 24, 2020
The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosisJ A Arnaiz, C Rodrigues-Silva, G Mezquida, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 17, 2026
The genetic architecture of autistic traits and negative symptoms in non-affective first-episode psychosis: an exploratory longitudinal studyG Mezquida, A Perez-Ramos, N Guasch-Capella, et al.
Schizophrenia Bulletin|February 22, 2020
Examining Gene-Environment Interactions Using Aggregate Scores in a First-Episode Psychosis CohortSergi Mas, Daniel Boloc, Natalia Rodríguez, et al.
Pageof 35